Abstract:Background: Recently, celastrol shows great potential for inducing apoptosis in the treatment of leukemia, especially acute promyelocytic leukemia. However, the mechanism is poorly understood. Metabolomics provides overall understanding of biological mechanisms by surveying small molecules, which contributes to the illustration of celastrol's action mode. Methods: We treated nude mice bearing xenografts of HL-60 cell in vivo and HL-60 cell as well as NB-4 cell in vitro with celastrol. UPLC coupled to an Orbitrap mass spectrometer was used for a hypothesis free metabolomics analysis of HL-60 in vivo, and was used for targeted L-cysteine analysis of HL-60 and NB-4 cells. Flow cytometry analysis was performed to detect the mitochondrial membrane potential, production of reactive oxygen species (ROS) and percentage of apoptosis. Western blot was conducted to detect the protein level of p53, Bax, cleaved caspase 9 and cleaved caspase 3. Findings: Celastrol inhibited tumor growth, induced apoptosis, and up-regulated pro-apoptotic proteins in xenograft tumor mice model. Metabolomics profiles delineated cysteine metabolism was the key changed metabolism after celastrol treatment in HL-60 cells in vivo. Celastrol decreased L-cysteine in HL-60 cells. The supplementation of acetylcysteine reversed the ROS and apoptosis induced by celastrol, and reversed the dramatic decline of mitochondrial membrane potential and the up-regulation of pro-apoptotic proteins in HL-60 cells. Celastrol decreased L-cysteine, and acetylcysteine reversed ROS and apoptosis induced by celastrol in NB-4 cells. Interpretation: We firstly identified cysteine metabolism/ROS/p53/Bax/caspase 9/caspase 3 pathway in celastrol-triggered apoptosis of APL cells, providing a novel mechanism underlying which celastrol might be used for the treatment of acute promyelocytic leukemia. Funding: This study was supported by grants from the National Natural Science Foundation of China (81872650, 81503134, 81573182); the Key Natural Science Foundation of the Jiangsu Higher Education Institutions of China (18KJA320003); the Key Project of the Science and Technology Development Foundation of Nanjing Medical University (2014NJMUZD005); the Key Research & Development Plan of Jiangsu Province (BE2017628); the Southeast University & Nanjing Medical University Collaborative Research Project (2242018K3DN25); the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Declaration of Interest: The authors declare that they have no competing interests.Ethical Approval: All procedures performed in studies involving animals were in accordance with the ethical standards of Nanjing Medical 419 University Institutional Animal Care and Use Committee.

Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity

Celastrol Inhibits Cancer Metastasis by Suppressing M2-like Polarization of Macrophages.

NF-Kappa B Modulation Is Involved in Celastrol Induced Human Multiple Myeloma Cell Apoptosis

Celastrol Causes Apoptosis and Cell Cycle Arrest in Rat Glioma Cells

Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway

Celastrol Induces the Apoptosis of Breast Cancer Cells and Inhibits Their Invasion Via Downregulation of MMP-9

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma

Celastrol Induces Apoptosis and Autophagy Via the ROS/JNK Signaling Pathway in Human Osteosarcoma Cells: an in Vitro and in Vivo Study

Dihydrocelastrol Inhibits Multiple Myeloma Cell Proliferation And Promotes Apoptosis Through Erk1/2 And Il-6/Stat3 Pathways In Vitro And In Vivo

Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells

Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells

Celastrol promotes apoptosis of human osteosarcoma HOS cells through endoplasmic reticulum stress pathway

Celastrol inhibits mouse B16-F10 melanoma cell survival by regulating the PI3K/AKT/mTOR signaling pathway and repressing HIF-1α expression

Celastrol Induces Apoptosis in Non-Small-Cell Lung Cancer A549 Cells Through Activation of Mitochondria- and Fas/Fasl-Mediated Pathways

Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.

Celastrol suppresses human pancreatic cancer via m6A-YTHDF3-mediated downregulation of Claspin and Bcl-2

Celastrol Inhibits Canine Mammary Tumor Cells by Inducing Apoptosis via the Caspase Pathway

Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity.

Metabolomics Reveals Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis of Acute Promyelocytic Leukemia Cells

Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the C-Myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses.

Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation.